Skip to main content
BRBR logo

BRBR · Bellring Brands, Inc.

Track BRBR — free
$9.22 +0.01 (+0.05%)
Market Cap
$1.07B
Shares
116.28M
Volume · Oct 28 1.21M Avg daily vol (3M) 3.82M

Price & Indicators

Drag to pan · scroll to zoom
20d MA 50d MA 200d MA Earnings Filing Insider Congress Investor day
Close$9.21 Open$9.65 Day$9.05–9.65 52W close$7.40–33.30 Avg vol 30d4.2M Short int12.3M · 10.6% float · 2.7d Short vol38% Last earningsAug 4, 2026 DataJan 2020–Oct 2026 Filing10-Q · Aug 4

Up next

Next earnings call
Nov 3, 2026 Est · unconfirmed · in 1 wks
filed Aug 4, 2026
call held Aug 4, 2026

Metrics snapshot

Useful current figures from the complete screener profile.

Revenue (TTM)
$2.35B
Trailing 12 months
Net income (TTM)
$171.40M
Trailing 12 months
Revenue growth YoY
+4.2%
Year over year
Operating margin
13.3%
Trailing 12 months
P / E (TTM)
6.5
Trailing earnings · reciprocal yield 15.4%
FCF yield
21.0%
TTM · current market cap
Return on invested capital
37.2%
Trailing 12 months
Net cash
−$1.08B
Latest balance sheet
Dividend yield
—
Trailing 12 months
Shares change YoY
-8.9%
Year over year · fewer shares
Price change (1Y)
-71.1%
Trailing year
Short interest
10.6%
Latest settlement · 2.7 days to cover
View all 122 metrics

AI Brief

Q3 FY26 earnings call · Aug 4, 2026
Q3 FY26

TL;DR. BellRing beat Q3 net sales expectations (+4% YoY to $570.4M) but cut its fiscal 2026 adjusted EBITDA outlook to $275–$295M, citing a $10M excess bottle inventory charge, sharply higher freight costs, and continued input cost inflation; the new CEO outlined price increases, productivity actions, and innovation launches aimed at improving margins in fiscal 2027.

Bullish
  • + Q3 net sales of $570.4M rose 4% YoY, ahead of expectations, driven by both Premier Protein and Dymatize.
  • + Dymatize net sales jumped 27% in Q3 with volumes up 6% and inflation-driven price/mix up 21%.
  • + Company announced a double-digit price increase on Premier Shakes plus additional powder pricing effective Q1 FY27 to address input cost inflation and rebuild margins.
  • + Premier RTD household penetration and repeat rate remain #1 in the RTD category, with TDPs up 27% YoY.
Bearish
  • − Q3 adjusted gross margin fell to 27.7% from 35.1% YoY due to protein/freight inflation, tariffs, and a $10M excess bottle inventory charge.
  • − Freight rates have risen sharply and are expected to weigh ~140 bps on second-half margins.
  • − Q4 FY26 adjusted EBITDA margin guided to ~10%, reflecting continued commodity/freight inflation, promotional intensity, and ~100 bps inventory headwind.
  • − Net leverage expected to rise to ~4.0x by fiscal year-end driven by a sizable Q4 legal settlement payment.

AI-generated from the earnings call and 8-K · may contain errors · not investment advice

Equibles Rating

blended score · not investment advice
Overall
Sell
SellHoldBuy
Technical Neutral Momentum Weak Sentiment Neutral Fundamentals Strong Quant / Vol Very High
Market backdrop VIX 17.5 · elevated Equity put/call 0.59
Technical
price trend
Neutral
50 / 200-day cross No cross
Price vs 200-day avg −32%
below
Price vs 50-day avg −0%
below
RSI (14) 53
neutral
MACD trend Positive
52-week position 7%
near low
Volume (OBV) Confirms
volume backs price
Momentum
relative strength
Weak
1-month return +19%
trailing
6-month return −17%
trailing
YTD return −66%
this year
Relative strength −22%
vs S&P · 6-mo
Sentiment
smart money
Neutral
Trend (MA cross) No cross
50d $9 › 200d $14 — 200d above 50d
Institutional flow Accumulating
76 of 366 funds reported for Sep 30 · net +725.0K sh shares · +9 new
Insider flow Accumulating
Net +$20.0K over 90 days · 0% sells
Short interest Rising
10.60% of float · ▲ +0.6% MoM · 2.7 days cover
Volume signal Normal
Volume near normal
Institution breadth Steady
366 holders — mid 3-yr range
Squeeze score 65
elevated · 0–100
Fundamentals
Strong
Revenue growth +16%
Y/Y
Gross margin 33%
contracting
EPS growth −10%
Y/Y
Valuation P/E 6.5
below peers
Buyback $506.9M
remaining
Balance sheet $1.0B
net debt
Quant / Vol
risk profile
Very High
Volatility 71%
annualized · 1-yr
Max drawdown −78%
past year
ATR 5.4%
of price · 14-day

Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.

Guidance & track record

Beat or met 4 of last 6
Latest guidance · from the Earnings Call filed May 5, 2026
second half
Adjusted EBITDA margin Non-GAAP 15%
full year
Advertising investment as a percent of sales 4%
third quarter
Adjusted EBITDA margin Non-GAAP 16%
Previous outlook earlier release · from the Earnings Call filed Nov 18, 2025

Still-open targets the latest release did not restate under the same label.

Long-term net sales growth algorithm · long-term 7% – 9%
Adjusted EBITDA margin algorithm · long-term 18% – 20%
Adjusted EBITDA margin · Q1 16%
Prior guidance period ended · from the Earnings Call filed Aug 4, 2026
Adjusted EBITDA margin · fourth quarter 10%
Guided vs delivered · last 6 settled
Net sales fiscal year 2025
guided $2.28B – $2.32B
$2.32B In line
Net sales fiscal year 2024
guided $1.96B – $2B
$2B In line
Net sales fiscal year 2023
guided $1.63B – $1.67B
$1.67B In line
Net sales fiscal year 2022
guided $1.39B – $1.42B
$1.37B Miss −2.4%

Guidance from company 8-Ks · delivered figures from as-reported statements · no analyst estimates involved.

Technicals

trend & momentum for long-term holders Neutral
2 · 4 · 1
50 / 200-day cross
No cross Neutral
Price vs 200-day avg
−32% Bearish
Price vs 50-day avg
−0% Neutral
RSI (14)
53 Neutral
MACD trend
Positive Bullish
52-week position
7% Bearish
Volume (OBV)
Confirms Neutral
Market signals — smart money & positioning
Bullish · 2 of 6
Trend (MA cross) No cross
50d $9 › 200d $14 — 200d above 50d
Institutional flow Accumulating
76 of 366 funds reported for Sep 30 · net +725.0K sh shares · +9 new
Insider flow Accumulating
Net +$20.0K over 90 days · 0% sells
Short interest Rising
10.60% of float · ▲ +0.6% MoM · 2.7 days cover
Volume signal Normal
Volume near normal
Institution breadth Steady
366 holders — mid 3-yr range
Price context
position in its 52-week range
Range low $7 Now $9 · 7% Range high $33
vs 200-day avg -32% vs 50-day avg 0%

Illustrative technical + ownership context — a signal mix, not investment advice.

Key metrics

the company's own KPIs, from written earnings releases and filings
Metric Latest Period YoY
Adjusted Diluted Earnings per Common Share non-GAAP $0.81 Nine Months Ended June 30, 2026 —
Adjusted EBITDA non-GAAP $222.4M nine months ended June 30, 2026 —
Adjusted EBITDA as a percentage of Net Sales non-GAAP 13% Nine Months Ended June 30, 2026 —
Adjusted gross profit non-GAAP $157.9M third quarter —
GAAP → non-GAAP reconciliation
GAAP Gross Profit 163.3M
-5.4M Mark-to-market adjustments on commodity hedges
= Adjusted Gross Profit 157.9M
Adjusted Gross Profit as a percentage of Net Sales non-GAAP 27.7% Three Months Ended June 30, 2026 —
Adjusted net earnings non-GAAP $96M the nine months ended June 30, 2026 —
Average price per share $15.66 the three months ended June 30, 2026 filing —
Dollar consumption of Dymatize powder and RTD products 2.7% 13-week period ended June 28, 2026 —
Dollar consumption of Premier Protein RTD shakes 6% 13-week period ended June 28, 2026 —
Dymatize consumption growth 3% Q3 FY2026 —
Premier Protein RTD consumption growth excluding eCommerce promotion timing shift non-GAAP 5% Q3 FY2026 —
Premier Protein RTD shake dollar share 21.9% Q3 FY2026 —
Premier Protein RTD total points of distribution (TDP) growth 27% Q3 FY2026 —
Remaining share repurchase authorization $506.9M As of June 30, 2026 —
Share of RTD category volumes sold on price reduction 17% Q3 FY2026 —
Shares repurchased 4.9M nine months ended June 30, 2026 —
Total Number of Shares Purchased 638,643 the three months ended June 30, 2026 filing —
Total share repurchase cost $10.1M the three months ended June 30, 2026 filing —

Figures exactly as the company stated them in writing · click a metric with a to chart its history · period links open the stating document · "filing" marks figures stated in the 10-K/10-Q · YoY needs an exactly comparable prior-year period

Versus peers

Packaged Foods — same industry group
Open screener →
Company Mkt cap YTD Rev growth Y/Y P/E Short % shares
BRBR
Bellring Brands, Inc.
this stock
$1.07B -65.5% +16.1% 6.5 10.6%
JBS
Jbs N.V.
$39.54B -16.6% — — 1.3%
KHC
Kraft Heinz Co
$29.33B -0.8% -0.1% — 8.2%
GIS
General Mills Inc
$17.90B -28.0% +4.1% — 7.1%
SJM
J M SMUCKER Co
$13.38B +30.3% +3.7% — 3.8%

Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding

At a glance

key data from every section
Ownership
Institutional Holders Accumulating
Holders
350
% held
116.0%
Reported
76 of 366
Top holder
BlackRock, Inc.
Held Float
View
Held by Funds
Fund positions
274
View
Short & Settlement
Short Interest Rising
Shares short
12.3M
Days to cover
2.7d
Change
+75.7K sh
View
Short Volume
Short vol %
38%
As of
Oct 27, 2026
Short Total
View
Fails to Deliver
FTD shares
1.8K
Value
$15.4K
As of
Sep 24, 2026
View
Off-Exchange
Off-exchange %
52.7%
Week of
Sep 21, 2026
Off-exch Lit
View
Smart Money
Insider Trades Net buying
Net (90d)
+$20.0K
Buyers / Sellers
1 / 0
Buyers Sellers
View
Congressional Trades Sell
Member
Cindy Axne
Amount
$1.0K–$15.0K
Traded
Jun 15, 2022
View
Financials
Financials
Revenue (FY)
$2.3B
Net income (FY)
$216.2M
EPS diluted
$1.68
View
Buybacks
Remaining
$506.9M
View
Filings
SEC Filings
Latest
8-K
Filed
Aug 4, 2026
This year
10
View
Proposed Sales
Value
$122.8K
Shares
4.0K
Filed
Dec 1, 2025
View
Earnings & Events
Webcasts
Last webcast
Aug 4, 2026
View

Performance

5D 20D 120D MTD YTD
BRBR -3.2% +18.8% -17.0% +19.8% -65.5%
SPY +0.1% +0.7% +4.9% +0.9% +12.9%
vs SPY -3.2% +18.1% -21.9% +18.9% -78.4%

Capital returns

Buyback program · as of Jun 30, 2026
Authorized
—
Spent (derived)
—
Remaining
$506.90M

Dividends per share over the trailing 365 days by ex-date · buyback figures as last reported in SEC filings ("spent" derived as authorized − remaining; when several programs run concurrently, authorized is their combined total per the newest filing) · components shown separately — trailing-year buyback spend isn't tracked, so no combined shareholder yield is derived.

Key facts CIK 1772016 CUSIP 07831C103 13F (30d) 59 filings 54 filers Visit website Investor relations